<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:02:16Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10745208" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10745208</identifier>
        <datestamp>2023-12-22</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLOS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10745208</article-id>
              <article-id pub-id-type="pmcid">PMC10745208</article-id>
              <article-id pub-id-type="pmc-uid">10745208</article-id>
              <article-id pub-id-type="pmid">38134136</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0289719</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-23-20136</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Study Protocol</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Cerebrovascular Diseases</subject>
                      <subj-group>
                        <subject>Stroke</subject>
                        <subj-group>
                          <subject>Ischemic Stroke</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Neurology</subject>
                    <subj-group>
                      <subject>Cerebrovascular Diseases</subject>
                      <subj-group>
                        <subject>Stroke</subject>
                        <subj-group>
                          <subject>Ischemic Stroke</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Stroke</subject>
                      <subj-group>
                        <subject>Ischemic Stroke</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Blood Pressure</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Neurochemistry</subject>
                      <subj-group>
                        <subject>Neuromodulation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Neuroscience</subject>
                    <subj-group>
                      <subject>Neurochemistry</subject>
                      <subj-group>
                        <subject>Neuromodulation</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Head</subject>
                      <subj-group>
                        <subject>Ears</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Anatomy</subject>
                    <subj-group>
                      <subject>Head</subject>
                      <subj-group>
                        <subject>Ears</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Surgical and Invasive Medical Procedures</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Cardiology</subject>
                    <subj-group>
                      <subject>Heart Rate</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Research Design</subject>
                    <subj-group>
                      <subject>Clinical Research Design</subject>
                      <subj-group>
                        <subject>Adverse Events</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Cerebrovascular Diseases</subject>
                      <subj-group>
                        <subject>Stroke</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Neurology</subject>
                    <subj-group>
                      <subject>Cerebrovascular Diseases</subject>
                      <subj-group>
                        <subject>Stroke</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Stroke</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Transauricular nerve stimulation in acute ischaemic stroke requiring mechanical thrombectomy: Protocol for a phase 2A, proof-of-concept, sham-controlled randomised trial</article-title>
                <alt-title alt-title-type="running-head">Transauricular nerve stimulation in acute ischaemic stroke</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0565-5164</contrib-id>
                  <name>
                    <surname>Ackland</surname>
                    <given-names>Gareth L.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Martin</surname>
                    <given-names>Tim</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Joseph</surname>
                    <given-names>Mareena</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1740-6165</contrib-id>
                  <name>
                    <surname>Dias</surname>
                    <given-names>Priyanthi</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7083-3062</contrib-id>
                  <name>
                    <surname>Hameed</surname>
                    <given-names>Rizwan</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gutierrez del Arroyo</surname>
                    <given-names>Ana</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hewson</surname>
                    <given-names>Russ</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8664-3001</contrib-id>
                  <name>
                    <surname>Abbott</surname>
                    <given-names>Tom E. F.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Spooner</surname>
                    <given-names>Oliver</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bhogal</surname>
                    <given-names>Pervinder</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, United Kingdom</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Stroke Medicine, London, Royal London Hospital, London, Barts Health NHS Trust, London, United Kingdom</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Interventional Neuroradiology, Royal London Hospital, London, Barts Health NHS Trust, London, United Kingdom</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Carels</surname>
                    <given-names>Vanessa</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>PLoS ONE, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>INNOVATE-UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>g.ackland@qmul.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>22</day>
                <month>12</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>18</volume>
              <issue>12</issue>
              <elocation-id>e0289719</elocation-id>
              <history>
                <date date-type="received">
                  <day>30</day>
                  <month>6</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>7</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 Ackland et al</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Ackland et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0289719.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>Labile blood pressure after acute ischaemic stroke requiring mechanical thrombectomy is independently associated with poor patient outcomes.</p>
                </sec>
                <sec id="sec002">
                  <title>Objectives</title>
                  <p>This study protocol describes is designed to determine whether transauricular nerve stimulation, improves baroreflex sensitivity, reduces blood pressure variability in the first 24 hours after acute ischaemic stroke requiring mechanical thrombectomy.</p>
                </sec>
                <sec id="sec003">
                  <title>Design: Phase 2A, proof-of-concept, sham-controlled randomised trial</title>
                  <p>Methods and Analysis: 36 individuals undergoing mechanical thrombectomy for acute ischaemic stroke with established hypertension aged &gt;18 years will be randomly allocated to receive bilateral active or sham transauricular nerve stimulation for the duration of the mechanical thrombectomy procedure (AffeX-CT/001 investigational device). The intervention will be repeated for 1h the morning following the mechanical thrombectomy. Non-invasive blood pressure will be measured ≥2h for 24h after mechanical thrombectomy. Holter electrocardiographic monitoring will be recorded during transauricular nerve stimulation. Participants, clinicians and investigators will be masked to treatment allocations. The primary outcome will be the coefficient of variation of systolic blood pressure. Secondary outcomes include additional estimates of blood pressure variability and time/frequency-domain measures of autonomic cardiac modulation An adjusted sample size of 36 patients is required to have a 90% chance of detecting, as significant at the 5% level, a difference in the coefficient of variation in systolic blood pressure of 5±4mmHg between sham and active stimulation [assuming 5% non-compliance rate in each group].</p>
                  <p>Ethics: confirmed on 16 March 2023 by HRA and Health and Care Research Wales ethics committee (reference 23/WA/0013)</p>
                </sec>
                <sec id="sec004">
                  <title>Discussion</title>
                  <p>This study will provide proof-of-concept data that examines whether non-invasive autonomic neuromodulation can be used to favourably modify blood pressure and autonomic control after acute ischaemic stroke requiring mechanical thrombectomy.</p>
                </sec>
                <sec id="sec005">
                  <title>Trial registration</title>
                  <p><bold>Trial registration number:</bold><ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT05417009" ext-link-type="uri">NCT05417009</ext-link>.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100006041</institution-id>
                      <institution>Innovate UK</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>Afferent Medical Solutions</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0565-5164</contrib-id>
                    <name>
                      <surname>Ackland</surname>
                      <given-names>Gareth L.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>UK-RI INNOVATE-UK award.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="3"/>
                <table-count count="0"/>
                <page-count count="11"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec006">
              <title>Background</title>
              <p>Mechanical thrombectomy has revolutionised the management of ischaemic stroke [<xref rid="pone.0289719.ref001" ref-type="bibr">1</xref>], but more than 50% of patients do not regain functional independence [<xref rid="pone.0289719.ref002" ref-type="bibr">2</xref>]. Loss of autonomic variability is strongly associated with adverse outcomes after ischaemic stroke [<xref rid="pone.0289719.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0289719.ref004" ref-type="bibr">4</xref>]. Higher systolic BPV and impaired baroreflex sensitivity are independently associated with an unfavourable outcome after stroke independently of absolute blood pressure [<xref rid="pone.0289719.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0289719.ref006" ref-type="bibr">6</xref>]. Impaired cardiovascular control adds prognostic value to the National Institutes of Health Stroke Scale [<xref rid="pone.0289719.ref004" ref-type="bibr">4</xref>].</p>
              <p>Autonomic neuromodulation by vagus nerve stimulation paired with rehabilitation improves recovery after stroke [<xref rid="pone.0289719.ref007" ref-type="bibr">7</xref>]. Earlier autonomic neuromodulation during the acute phase of ischaemic stroke has not been tested, even though restoring baroreflex control and vagal activity may reduce blood pressure variability and potentially limit further cardiovascular complications [<xref rid="pone.0289719.ref008" ref-type="bibr">8</xref>–<xref rid="pone.0289719.ref010" ref-type="bibr">10</xref>]. Activation of parasympathetic innervation of blood vessels may also increase cerebral blood flow [<xref rid="pone.0289719.ref011" ref-type="bibr">11</xref>]. Experimental vagal nerve stimulation in rats inhibits ischemia-induced immune activation in cortical tissue [<xref rid="pone.0289719.ref012" ref-type="bibr">12</xref>] and dampens systemic inflammation [<xref rid="pone.0289719.ref013" ref-type="bibr">13</xref>]. Restoring autonomic control may limit immunosuppression and reduce post-stroke infections, which affect≈30% of patients, delay recovery and accelerate death [<xref rid="pone.0289719.ref014" ref-type="bibr">14</xref>].</p>
              <p>Surgically implanted devices for autonomic neuromodulation, such as vagus nerve stimulators, are impractical in the context of acute stroke. A potential alternative is using non-invasive peripheral neuromodulation devices to attempt to restore autonomic control [<xref rid="pone.0289719.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0289719.ref016" ref-type="bibr">16</xref>]. Bilateral transcutaneous aurciular stimulation is a simple, safe, hand-held, low-cost approach to increase vagal activity and baroreflex sensitivity through non-invasive, painless stimulation of nerves located in the outer ear [<xref rid="pone.0289719.ref017" ref-type="bibr">17</xref>]. We have demonstrated that baroreflex sensitivity can be increased at the bedside by bilateral transcutaneous aurciular stimulation following acute trauma, where the development of baroreflex dysfunction also occurs rapidly after injury [<xref rid="pone.0289719.ref015" ref-type="bibr">15</xref>]. Here, we describe the protocol for a randomised sham-controlled device trial, hypothesizing that bilateral transauricular nerve stimulation lowers blood pressure variability in patients presenting with acute ischaemic stroke through increasing cardiac vagal autonomic tone.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec007">
              <title>Methods</title>
              <sec id="sec008">
                <title>Study design</title>
                <p>This is a single centre, triple-blind, open crossover, randomised sham-controlled trial (<xref rid="pone.0289719.g001" ref-type="fig">Fig 1</xref>) undertaken at Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.</p>
                <fig position="float" id="pone.0289719.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0289719.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>SPIRIT schedule.</title>
                  </caption>
                  <graphic xlink:href="pone.0289719.g001" position="float"/>
                </fig>
                <p>Ethical permission was granted on 16 March 2023 by HRA and Health and Care Research Wales ethics committee (reference 23/WA/0013). The trial was registered at NCT05417009 Authors will have access to information that could identify individual participants during or after data collection. The completed SPIRIT schedule is shown in <xref rid="pone.0289719.g001" ref-type="fig">Fig 1</xref>.</p>
              </sec>
              <sec id="sec009">
                <title>Inclusion criteria</title>
                <list list-type="bullet">
                  <list-item>
                    <p>age&gt;18 years;</p>
                  </list-item>
                  <list-item>
                    <p>undergoing mechanical thrombectomy for acute ischaemic stroke;</p>
                  </list-item>
                  <list-item>
                    <p>established hypertension and/or hypertensive on admission (defined as systolic BP &gt;140mmHg; diastolic BP &gt;90mmHg).</p>
                  </list-item>
                </list>
              </sec>
              <sec id="sec010">
                <title>Exclusion criteria</title>
                <list list-type="bullet">
                  <list-item>
                    <p>participation in a trial exploring similar biological mechanism; previous enrolment;</p>
                  </list-item>
                  <list-item>
                    <p>anatomical contraindication (local ear abnormalities);</p>
                  </list-item>
                  <list-item>
                    <p>pregnancy.</p>
                  </list-item>
                </list>
                <sec id="sec011">
                  <title>Ethics</title>
                  <p>Screening is conducted by the interventional radiology team, who alert the research team to patients accepted for an imminent thrombectomy. Since patients presenting with acute ischaemic stroke are frequently unable to consent for themselves due to neurological impairment, sedation or delirium, a professional representative will confirm assent for participation. Subsequent to this, where patients lack capacity, a patient representative will be approached for their written consent, documented in the patient notes with a copy given to the participant and/or relative.</p>
                </sec>
              </sec>
              <sec id="sec012">
                <title>Randomization</title>
                <p>Each CE-marked device (Totally TENS, Well-Life Healthcare Ltd<sup>TM</sup>) used for auricular nerve stimulation is sequentially randomised by the manufacturer to deliver either sham or active stimulation. For sham stimulation, a break in the ear leads made at time of manufacture ensures that no current can be delivered. Block randomisation (blocks of 4) will be undertaken (STATA).</p>
              </sec>
              <sec id="sec013">
                <title>Intervention</title>
                <p>Immediately after arrival in the interventional radiology suite, continuous ECG is recorded on a Holter monitor (Spacelabs, Hertford UK). Blood pressure will be measured at least every 2h over the first 24h after mechanical thrombectomy. Once sedation or general anaesthesia are induced (according to the clinical indication determined by the attending anesthesiologists), auricular nerve stimulation will be delivered by placing two conductive clips securely on both the left and right tragus areas of the outer ear, attached to the CE-marked device. Each device is pre-programmed with parameters set at 3mA current, pulse width 200μs and frequency 30Hz, as indicated by our previous study and through systematic review [<xref rid="pone.0289719.ref017" ref-type="bibr">17</xref>]. (<xref rid="pone.0289719.g002" ref-type="fig">Fig 2</xref>). All devices are calibrated by oscilloscope. The leads are removed from the ears at the end of the mechanical thrombectomy (defined as removal of femoral arterial sheath). The investigator will remain with the patient to ensure compliance and adherence to the protocol. The intervention will be repeated the morning following the mechanical thrombectomy procedure for 1 hour (provided the patient has not already been discharged or repatriated to their referring centre).</p>
                <fig position="float" id="pone.0289719.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0289719.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Study intervention and hypothesised outcomes.</title>
                    <p>Cartoon images for stroke, thrombectomy, lungs generated using Biorender [<xref rid="pone.0289719.ref018" ref-type="bibr">18</xref>].</p>
                  </caption>
                  <graphic xlink:href="pone.0289719.g002" position="float"/>
                </fig>
              </sec>
              <sec id="sec014">
                <title>Outcome assessments</title>
                <p>All outcome assessments are masked to treatment allocation until the final analysis.</p>
              </sec>
              <sec id="sec015">
                <title>Primary outcome</title>
                <p>The primary outcome will be the coefficient of variation of systolic blood pressure over the first 24h from start of mechanical thrombectomy.</p>
              </sec>
              <sec id="sec016">
                <title>Secondary outcomes</title>
                <p>Blood pressure variability in the first 24h after mechanical thrombectomy (standard deviation, average real variability, successive variation and residual standard deviation).</p>
                <list list-type="order">
                  <list-item>
                    <p>BPV formulae are provided in supplementary data. These measures take into account the distribution and linear trends of BP in an effort to reduce the dependency of BPV on mean BP level.</p>
                  </list-item>
                  <list-item>
                    <p>Autonomic cardiac modulation in the first 24h after mechanical thrombectomy (Holter monitoring).</p>
                  </list-item>
                  <list-item>
                    <p>Neurological recovery will be reported by recording serial NIH Stroke Scale (NIHSS) scores, an FDA-approved primary outcome measure for stroke in early phase II trials before and 24h after mechanical thrombectomy [<xref rid="pone.0289719.ref019" ref-type="bibr">19</xref>].</p>
                  </list-item>
                </list>
              </sec>
              <sec id="sec017">
                <title>Exploratory objectives</title>
                <p>Biomarkers for risk of infection (whole blood leukocyte transcriptomic changes after incubation at 37°C with sterile saline or 100ng/ml lipopolysaccharide for 4h) and myocardial injury (high-sensitivity troponin) will also be quantified (<xref rid="pone.0289719.g002" ref-type="fig">Fig 2</xref>).</p>
              </sec>
              <sec id="sec018">
                <title>Trial monitoring</title>
                <p>An independent Trial Monitoring Committee comprising two neurologists, an internal medicine specialist, neuroanaesthetist and a clinical neuroscientist will review the RCT on alternate months. The trial steering committee is responsible for recommendations to the trial management group regarding stopping or continuing the trial. If there are adverse events of concern that may involve the use of the device, a subgroup led the Trial steering committee chair will launch a study review.</p>
              </sec>
              <sec id="sec019">
                <title>Sample size estimation</title>
                <p>We estimated the sample size from data reported from the secondary analysis of the BEST study, which examined blood pressure variability and neurologic outcome after endovascular thrombectomy [<xref rid="pone.0289719.ref006" ref-type="bibr">6</xref>]. An adjusted sample size of 36 patients is required to have a 90% chance of detecting, as significant at the 5% level, a decrease in the coefficient of variation in systolic blood pressure from 15±4mmHg in the sham group to 10±4mmHg in the VAN group [assuming 5% non-compliance rate in each group].</p>
              </sec>
              <sec id="sec020">
                <title>Bias and blinding</title>
                <p>Patients, clinicians and investigators are blinded to the device allocation throughout data collection and analysis. For active stimulation, the current is typically imperceptible at 3mA [<xref rid="pone.0289719.ref015" ref-type="bibr">15</xref>]. If patients complain or are irritated by the device leads, the current will be reduced by 1mA until the discomfort is no longer reported. Patients, clinicians and investigators are also masked to the Holter data, which will be analysed offline by an independent investigator not involved with patient recruitment/device application who is also masked to the treatment allocations.</p>
              </sec>
              <sec id="sec021">
                <title>Data collection</title>
                <p>Continuous ECG is recorded by Holter monitor (Spacelabs, Hertford UK). Blood pressure will be measured at least every 2h over the first 24h after mechanical thrombectomy. Plasma will be stored at -80°C having been obtained after both intervention periods for exploratory analyses of biomarkers related to autonomic activation. These data will be collected by a member of the research team not involved with administering the interventions, and analysed by an independent member of the research team–both will be masked to the treatment allocations. Data will be entered electronically on a custom-designed database.</p>
              </sec>
              <sec id="sec022">
                <title>Statistical analysis</title>
                <p>Analyses will be conducted using the intention-to-treat principle, where all participants with a recorded outcome are analysed according to the treatment group to which they were randomised (<xref rid="pone.0289719.g003" ref-type="fig">Fig 3</xref>). Baseline participant characteristics will be presented and stratified according to treatment allocation. The primary outcome will be analysed using repeat-measures analysis of variance. For secondary outcomes, heart rate variability data, troponin and transcirptomics will also be compared in each group using repeat-measures analysis of variance. The significance level will be set at 0.05. A full statistical analysis plan will be developed prior to analysis and the end of the study, published online at <ext-link xlink:href="https://www.qmul.ac.uk/ccpmg/sops--saps/statistical-analysis-plans-saps" ext-link-type="uri">https://www.qmul.ac.uk/ccpmg/sops—saps/statistical-analysis-plans-saps</ext-link>.</p>
                <fig position="float" id="pone.0289719.g003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0289719.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>CONSORT diagram.</title>
                  </caption>
                  <graphic xlink:href="pone.0289719.g003" position="float"/>
                </fig>
              </sec>
              <sec id="sec023">
                <title>Trial management and data monitoring</title>
                <p>The Sponsor organization is Queen Mary University of London (QMUL). Daily trial management will be coordinated by a trial management group consisting of the Chief Investigator and his/her support staff. An independent study committee will oversee the trial, including assessing the safety of the intervention, reviewing relevant new external evidence, and monitoring the overall conduct of the trial. This committee consists of an independent clinical trialist, lay representative and an independent Chair.</p>
              </sec>
              <sec id="sec024">
                <title>Adverse events</title>
                <p>Prespecified and any other adverse events directly related to the trial intervention will be recorded (supplementary material).</p>
              </sec>
              <sec id="sec025">
                <title>Auditing</title>
                <p>The Sponsor will have oversight of the trial conduct. The trial team ensure compliance with the requirements of Good Clinical Practice including data quality control and safety reporting.</p>
              </sec>
              <sec id="sec026">
                <title>Dissemination plans</title>
                <p>This is an investigator-led study sponsored by the CI’s substantive employer, QMUL. The data collected will not be used to license/register any pharmaceuticals. Data arising from the research will be made available to the scientific community in a timely and responsible manner. An appointed lay representative will co-author a detailed scientific report, which will be submitted to a widely accessible scientific journal. Authorship of the final manuscript(s), interim publications, or abstracts will be decided according to active participation in the design, accrual of eligible participants and statistical analysis. Contributing/participating investigators will be acknowledged in the final manuscript.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec027">
              <title>Discussion</title>
              <p>Current treatments for ischemic stroke mainly focus on revascularization or reperfusion of cerebral blood flow to the infarcted tissue [<xref rid="pone.0289719.ref020" ref-type="bibr">20</xref>]. Despite advances with mechanical thrombectomy, reperfusion injury may exacerbate ischemic injury in patients with stroke. Experimental models suggest that autonomic neuromodulation, chiefly involving direct stimulation of the vagus nerve, may improve cognitive outcomes and minimise neuronal deficits [<xref rid="pone.0289719.ref021" ref-type="bibr">21</xref>].</p>
              <p>Autonomic neuromodulation by vagus nerve stimulation paired with rehabilitation improves recovery after stroke [<xref rid="pone.0289719.ref007" ref-type="bibr">7</xref>]. Earlier autonomic neuromodulation during the acute phase of ischaemic stroke has not been tested, even though restoring baroreflex control and vagal activity may reduce blood pressure variability and potentially limit further cardiovascular complications [<xref rid="pone.0289719.ref008" ref-type="bibr">8</xref>–<xref rid="pone.0289719.ref010" ref-type="bibr">10</xref>]. Activation of parasympathetic innervation of blood vessels may also increase cerebral blood flow [<xref rid="pone.0289719.ref011" ref-type="bibr">11</xref>]. Experimental vagal nerve stimulation in rats inhibits ischemia-induced immune activation in cortical tissue [<xref rid="pone.0289719.ref012" ref-type="bibr">12</xref>] and dampens systemic inflammation [<xref rid="pone.0289719.ref013" ref-type="bibr">13</xref>]. Restoring autonomic control may limit immunosuppression and reduce post-stroke infections, which affect≈30% of patients, delay recovery and accelerate death [<xref rid="pone.0289719.ref014" ref-type="bibr">14</xref>]. The concept of non-invasive approaches to improve blood pressure control during the acute phase of ischaemic stroke by enhancing efferent vagal activity is very attractive [<xref rid="pone.0289719.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0289719.ref023" ref-type="bibr">23</xref>]. However, whether transauricular nerve stimulation results in vagal activation specifically remains uncertain, with variable components of heart rate variability reportedly altered by active stimulation in volunteers [<xref rid="pone.0289719.ref024" ref-type="bibr">24</xref>]. Very few clinical studies have actively sought to measure cardiac autonomic modulation at the same time as the primary outcome has been recorded [<xref rid="pone.0289719.ref017" ref-type="bibr">17</xref>]. Although the assessment of autonomic function is particularly challenging during acute tissue injury in patients, we found that only active transauricular nerve stimulation altered HRV measures indicative of increased baroreflex sensitivity [<xref rid="pone.0289719.ref015" ref-type="bibr">15</xref>]. These data were consistent with our systematic review that identified stimulation parameters that alter heart rate variability [<xref rid="pone.0289719.ref017" ref-type="bibr">17</xref>]. A 60 minute period of daily stimulation has not been associated with any major adverse events [<xref rid="pone.0289719.ref017" ref-type="bibr">17</xref>]. Moreover, our data were consistent with numerous previous reports detailing that hypertensive individuals have blunted baroreflex sensitivity. which is positively related to heart rate variability and inversely related to blood pressure variability. Baroreflex sensitivity is also inversely correlated with ambulatory blood pressure in healthy non-hypertensive humans [<xref rid="pone.0289719.ref025" ref-type="bibr">25</xref>].</p>
              <p>To reduce bias, which is common in studies of non-invasive autonomic neuromodulation [<xref rid="pone.0289719.ref017" ref-type="bibr">17</xref>], we will utilise a triple-blind, randomised controlled design. The use of a sham stimulation device is critical to minimise participant and investigator biases. Far more invasive studies have successfully recruited patients into trials where sham procedures served as the key control in cardiac [<xref rid="pone.0289719.ref026" ref-type="bibr">26</xref>] and noncardiac orthopaedic surgery [<xref rid="pone.0289719.ref027" ref-type="bibr">27</xref>] Our prospective randomised study will ensure that there are a high number of BP measurements (37) for the 24 hour exposure period, which increase the accuracy of estimating BPV. Although we will not be able to control concomitant medical interventions that may alter BP (such as mode of anaesthesia/sedation), multi-level statistical analytic techniques will account for these potential confounding factors. In contrast to observational studies such as BEST, the intervention can directly provide further insight into whether BPV is a modifiable factor rather than merely being an epiphenomenon.</p>
              <p>In summary, this randomised sham-controlled trial will assess whether non-invasive autonomic neuromodulation may reduce blood pressure variability and favourably alter autonomic control. This non-pharmacologic approach may be broadly generalisable to help improve cardiovascular health after acute ischaemic stroke.</p>
            </sec>
            <sec id="sec028" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0289719.s001" position="float" content-type="local-data">
                <label>S1 Checklist</label>
                <caption>
                  <title>SPIRIT 2013 checklist: Recommended items to address in a clinical trial protocol and related documents*.</title>
                  <p>(DOC)</p>
                </caption>
                <media xlink:href="pone.0289719.s001.doc">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0289719.s002" position="float" content-type="local-data">
                <label>S1 File</label>
                <caption>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0289719.s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0289719.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Bhogal</surname><given-names>P</given-names></name>, <name><surname>Andersson</surname><given-names>T</given-names></name>, <name><surname>Maus</surname><given-names>V</given-names></name>, <name><surname>Mpotsaris</surname><given-names>A</given-names></name>, <name><surname>Yeo</surname><given-names>L</given-names></name>. <article-title>Mechanical Thrombectomy-A Brief Review of a Revolutionary new Treatment for Thromboembolic Stroke</article-title>. <source>Clin Neuroradiol</source>. <year>2018</year>;<volume>28</volume>(<issue>3</issue>):<fpage>313</fpage>–<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00062-018-0692-2</pub-id> .<?supplied-pmid 29744519?><pub-id pub-id-type="pmid">29744519</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Goyal</surname><given-names>M</given-names></name>, <name><surname>Menon</surname><given-names>BK</given-names></name>, <name><surname>van Zwam</surname><given-names>WH</given-names></name>, <name><surname>Dippel</surname><given-names>DW</given-names></name>, <name><surname>Mitchell</surname><given-names>PJ</given-names></name>, <name><surname>Demchuk</surname><given-names>AM</given-names></name>, <etal>et al</etal>. <article-title>Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>387</volume>(<issue>10029</issue>):<fpage>1723</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(16)00163-X</pub-id> .<?supplied-pmid 26898852?><pub-id pub-id-type="pmid">26898852</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Jafari</surname><given-names>M</given-names></name>, <name><surname>Desai</surname><given-names>A</given-names></name>, <name><surname>Damani</surname><given-names>R</given-names></name>. <article-title>Blood pressure management after mechanical thrombectomy in stroke patients</article-title>. <source>J Neurol Sci</source>. <year>2020</year>;<volume>418</volume>:<fpage>117140</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jns.2020.117140</pub-id> .<?supplied-pmid 32961389?><pub-id pub-id-type="pmid">32961389</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>S</given-names></name>, <name><surname>Xiong</surname><given-names>L</given-names></name>, <name><surname>Fan</surname><given-names>Y</given-names></name>, <name><surname>Mok</surname><given-names>VCT</given-names></name>, <name><surname>Wong</surname><given-names>KS</given-names></name>, <name><surname>Leung</surname><given-names>TW</given-names></name>. <article-title>Stroke Outcome Prediction by Blood Pressure Variability, Heart Rate Variability, and Baroreflex Sensitivity</article-title>. <source>Stroke</source>. <year>2020</year>;<volume>51</volume>(<issue>4</issue>):<fpage>1317</fpage>–<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/STROKEAHA.119.027981</pub-id> .<?supplied-pmid 31964286?><pub-id pub-id-type="pmid">31964286</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Sykora</surname><given-names>M</given-names></name>, <name><surname>Diedler</surname><given-names>J</given-names></name>, <name><surname>Turcani</surname><given-names>P</given-names></name>, <name><surname>Hacke</surname><given-names>W</given-names></name>, <name><surname>Steiner</surname><given-names>T</given-names></name>. <article-title>Baroreflex: a new therapeutic target in human stroke?</article-title><source>Stroke</source>. <year>2009</year>;<volume>40</volume>(<issue>12</issue>):<fpage>e678</fpage>–<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/STROKEAHA.109.565838</pub-id> .<?supplied-pmid 19834010?><pub-id pub-id-type="pmid">19834010</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Mistry</surname><given-names>EA</given-names></name>, <name><surname>Mehta</surname><given-names>T</given-names></name>, <name><surname>Mistry</surname><given-names>A</given-names></name>, <name><surname>Arora</surname><given-names>N</given-names></name>, <name><surname>Starosciak</surname><given-names>AK</given-names></name>, <name><surname>De Los Rios La Rosa</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Blood Pressure Variability and Neurologic Outcome After Endovascular Thrombectomy: A Secondary Analysis of the BEST Study</article-title>. <source>Stroke</source>. <year>2020</year>;<volume>51</volume>(<issue>2</issue>):<fpage>511</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/STROKEAHA.119.027549</pub-id> ; PubMed Central PMCID: PMC8010595.<?supplied-pmid 31813361?><pub-id pub-id-type="pmid">31813361</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Dawson</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>CY</given-names></name>, <name><surname>Francisco</surname><given-names>GE</given-names></name>, <name><surname>Cramer</surname><given-names>SC</given-names></name>, <name><surname>Wolf</surname><given-names>SL</given-names></name>, <name><surname>Dixit</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial</article-title>. <source>Lancet</source>. <year>2021</year>;<volume>397</volume>(<issue>10284</issue>):<fpage>1545</fpage>–<lpage>53</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00475-X</pub-id> ; PubMed Central PMCID: PMC8862193.<?supplied-pmid 33894832?><pub-id pub-id-type="pmid">33894832</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Maier</surname><given-names>B</given-names></name>, <name><surname>Turc</surname><given-names>G</given-names></name>, <name><surname>Taylor</surname><given-names>G</given-names></name>, <name><surname>Blanc</surname><given-names>R</given-names></name>, <name><surname>Obadia</surname><given-names>M</given-names></name>, <name><surname>Smajda</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Prognostic Significance of Pulse Pressure Variability During Mechanical Thrombectomy in Acute Ischemic Stroke Patients</article-title>. <source>J Am Heart Assoc</source>. <year>2018</year>;<volume>7</volume>(<issue>18</issue>):<fpage>e009378</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/JAHA.118.009378</pub-id> ; PubMed Central PMCID: PMC6222945.<?supplied-pmid 30371208?><pub-id pub-id-type="pmid">30371208</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Stavrakis</surname><given-names>S</given-names></name>, <name><surname>Humphrey</surname><given-names>MB</given-names></name>, <name><surname>Scherlag</surname><given-names>BJ</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Jackman</surname><given-names>WM</given-names></name>, <name><surname>Nakagawa</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation</article-title>. <source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>65</volume>(<issue>9</issue>):<fpage>867</fpage>–<lpage>75</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jacc.2014.12.026</pub-id> ; PubMed Central PMCID: PMC4352201.<?supplied-pmid 25744003?><pub-id pub-id-type="pmid">25744003</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Mastitskaya</surname><given-names>S</given-names></name>, <name><surname>Marina</surname><given-names>N</given-names></name>, <name><surname>Gourine</surname><given-names>A</given-names></name>, <name><surname>Gilbey</surname><given-names>MP</given-names></name>, <name><surname>Spyer</surname><given-names>KM</given-names></name>, <name><surname>Teschemacher</surname><given-names>AG</given-names></name>, <etal>et al</etal>. <article-title>Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones</article-title>. <source>Cardiovasc Res</source>. <year>2012</year>;<volume>95</volume>(<issue>4</issue>):<fpage>487</fpage>–<lpage>94</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cvr/cvs212</pub-id> ; PubMed Central PMCID: PMC3422080.<?supplied-pmid 22739118?><pub-id pub-id-type="pmid">22739118</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Roloff</surname><given-names>EV</given-names></name>, <name><surname>Tomiak-Baquero</surname><given-names>AM</given-names></name>, <name><surname>Kasparov</surname><given-names>S</given-names></name>, <name><surname>Paton</surname><given-names>JF</given-names></name>. <article-title>Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?</article-title><source>J Physiol</source>. <year>2016</year>;<volume>594</volume>(<issue>22</issue>):<fpage>6463</fpage>–<lpage>85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1113/JP272450</pub-id> ; PubMed Central PMCID: PMC5108906.<?supplied-pmid 27357059?><pub-id pub-id-type="pmid">27357059</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Ay</surname><given-names>I</given-names></name>, <name><surname>Nasser</surname><given-names>R</given-names></name>, <name><surname>Simon</surname><given-names>B</given-names></name>, <name><surname>Ay</surname><given-names>H</given-names></name>. <article-title>Transcutaneous Cervical Vagus Nerve Stimulation Ameliorates Acute Ischemic Injury in Rats</article-title>. <source>Brain Stimul</source>. <year>2016</year>;<volume>9</volume>(<issue>2</issue>):<fpage>166</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.brs.2015.11.008</pub-id> ; PubMed Central PMCID: PMC4789082.<?supplied-pmid 26723020?><pub-id pub-id-type="pmid">26723020</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Chavan</surname><given-names>SS</given-names></name>, <name><surname>Pavlov</surname><given-names>VA</given-names></name>, <name><surname>Tracey</surname><given-names>KJ</given-names></name>. <article-title>Mechanisms and Therapeutic Relevance of Neuro-immune Communication</article-title>. <source>Immunity</source>. <year>2017</year>;<volume>46</volume>(<issue>6</issue>):<fpage>927</fpage>–<lpage>42</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.immuni.2017.06.008</pub-id> ; PubMed Central PMCID: PMC5578398.<?supplied-pmid 28636960?><pub-id pub-id-type="pmid">28636960</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Westendorp</surname><given-names>WF</given-names></name>, <name><surname>Nederkoorn</surname><given-names>PJ</given-names></name>, <name><surname>Vermeij</surname><given-names>JD</given-names></name>, <name><surname>Dijkgraaf</surname><given-names>MG</given-names></name>, <name><surname>van de Beek</surname><given-names>D</given-names></name>. <article-title>Post-stroke infection: a systematic review and meta-analysis</article-title>. <source>BMC Neurol</source>. <year>2011</year>;<volume>11</volume>:<fpage>110</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2377-11-110</pub-id> ; PubMed Central PMCID: PMC3185266.<?supplied-pmid 21933425?><pub-id pub-id-type="pmid">21933425</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>ABU</given-names></name>, <name><surname>Bibawy</surname><given-names>P</given-names></name>, <name><surname>Althonayan</surname><given-names>JIM</given-names></name>, <name><surname>Majeed</surname><given-names>Z</given-names></name>, <name><surname>Gan</surname><given-names>WL</given-names></name>, <name><surname>Abbott</surname><given-names>TEF</given-names></name>, <etal>et al</etal>. <article-title>Effect of transauricular nerve stimulation on perioperative pain: a single-blind, analyser-masked, randomised controlled trial</article-title>. <source>Br J Anaesth</source>. <year>2023</year>;<volume>130</volume>(<issue>4</issue>):<fpage>468</fpage>–<lpage>76</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bja.2022.12.025</pub-id> ; PubMed Central PMCID: PMC10080471.<?supplied-pmid 36822987?><pub-id pub-id-type="pmid">36822987</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Clancy</surname><given-names>JA</given-names></name>, <name><surname>Mary</surname><given-names>DA</given-names></name>, <name><surname>Witte</surname><given-names>KK</given-names></name>, <name><surname>Greenwood</surname><given-names>JP</given-names></name>, <name><surname>Deuchars</surname><given-names>SA</given-names></name>, <name><surname>Deuchars</surname><given-names>J</given-names></name>. <article-title>Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity</article-title>. <source>Brain Stimul</source>. <year>2014</year>;<volume>7</volume>(<issue>6</issue>):<fpage>871</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.brs.2014.07.031</pub-id> .<?supplied-pmid 25164906?><pub-id pub-id-type="pmid">25164906</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>ABU</given-names></name>, <name><surname>Weber</surname><given-names>V</given-names></name>, <name><surname>Gourine</surname><given-names>AV</given-names></name>, <name><surname>Ackland</surname><given-names>GL</given-names></name>. <article-title>The potential for autonomic neuromodulation to reduce perioperative complications and pain: a systematic review and meta-analysis</article-title>. <source>Br J Anaesth</source>. <year>2022</year>;<volume>128</volume>(<issue>1</issue>):<fpage>135</fpage>–<lpage>49</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bja.2021.08.037</pub-id> .<?supplied-pmid 34801224?><pub-id pub-id-type="pmid">34801224</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref018">
                <label>18</label>
                <mixed-citation publication-type="other">Adapted from “Lung” template, <ext-link xlink:href="http://biorender.com" ext-link-type="uri">biorender.com</ext-link> [Internet]. 2023 [cited 27/07/2023]. Available from: <ext-link xlink:href="https://app.biorender.com/biorender-templates" ext-link-type="uri">https://app.biorender.com/biorender-templates</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Chalos</surname><given-names>V</given-names></name>, <name><surname>van der Ende</surname><given-names>NAM</given-names></name>, <name><surname>Lingsma</surname><given-names>HF</given-names></name>, <name><surname>Mulder</surname><given-names>M</given-names></name>, <name><surname>Venema</surname><given-names>E</given-names></name>, <name><surname>Dijkland</surname><given-names>SA</given-names></name>, <etal>et al</etal>. <article-title>National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke</article-title>. <source>Stroke</source>. <year>2020</year>;<volume>51</volume>(<issue>1</issue>):<fpage>282</fpage>–<lpage>90</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/STROKEAHA.119.026791</pub-id> ; PubMed Central PMCID: PMC6924951.<?supplied-pmid 31795895?><pub-id pub-id-type="pmid">31795895</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Fayad</surname><given-names>P.</given-names></name><article-title>Improved Prospects for Thrombectomy in Large Ischemic Stroke</article-title>. <source>N Engl J Med</source>. <year>2023</year>;<volume>388</volume>(<issue>14</issue>):<fpage>1326</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMe2300193</pub-id> .<?supplied-pmid 36762847?><pub-id pub-id-type="pmid">36762847</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Keser</surname><given-names>Z</given-names></name>, <name><surname>Feng</surname><given-names>W</given-names></name>. <article-title>Vagus Nerve Stimulation for Stroke Motor Recovery-What Is Next?</article-title><source>Transl Stroke Res</source>. <year>2022</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s12975-022-01041-4</pub-id> .<?supplied-pmid 35653016?><pub-id pub-id-type="pmid">35653016</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Cai</surname><given-names>PY</given-names></name>, <name><surname>Bodhit</surname><given-names>A</given-names></name>, <name><surname>Derequito</surname><given-names>R</given-names></name>, <name><surname>Ansari</surname><given-names>S</given-names></name>, <name><surname>Abukhalil</surname><given-names>F</given-names></name>, <name><surname>Thenkabail</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Vagus nerve stimulation in ischemic stroke: old wine in a new bottle</article-title>. <source>Front Neurol</source>. <year>2014</year>;<volume>5</volume>:<fpage>107</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fneur.2014.00107</pub-id> ; PubMed Central PMCID: PMC4067569.<?supplied-pmid 25009531?><pub-id pub-id-type="pmid">25009531</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Ma</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Niu</surname><given-names>F</given-names></name>, <name><surname>Feng</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Auricular vagus nerve stimulation promotes functional recovery and enhances the post-ischemic angiogenic response in an ischemia/reperfusion rat model</article-title>. <source>Neurochem Int</source>. <year>2016</year>;<volume>97</volume>:<fpage>73</fpage>–<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.neuint.2016.02.009</pub-id> .<?supplied-pmid 26964767?><pub-id pub-id-type="pmid">26964767</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Wolf</surname><given-names>V</given-names></name>, <name><surname>Kuhnel</surname><given-names>A</given-names></name>, <name><surname>Teckentrup</surname><given-names>V</given-names></name>, <name><surname>Koenig</surname><given-names>J</given-names></name>, <name><surname>Kroemer</surname><given-names>NB</given-names></name>. <article-title>Does transcutaneous auricular vagus nerve stimulation affect vagally mediated heart rate variability? A living and interactive Bayesian meta-analysis</article-title>. <source>Psychophysiology</source>. <year>2021</year>;<volume>58</volume>(<issue>11</issue>):<fpage>e13933</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/psyp.13933</pub-id> .<?supplied-pmid 34473846?><pub-id pub-id-type="pmid">34473846</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Hesse</surname><given-names>C</given-names></name>, <name><surname>Charkoudian</surname><given-names>N</given-names></name>, <name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Joyner</surname><given-names>MJ</given-names></name>, <name><surname>Eisenach</surname><given-names>JH</given-names></name>. <article-title>Baroreflex sensitivity inversely correlates with ambulatory blood pressure in healthy normotensive humans</article-title>. <source>Hypertension</source>. <year>2007</year>;<volume>50</volume>(<issue>1</issue>):<fpage>41</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.090308</pub-id> .<?supplied-pmid 17502489?><pub-id pub-id-type="pmid">17502489</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Uhe</surname><given-names>T</given-names></name>, <name><surname>Beimel</surname><given-names>S</given-names></name>, <name><surname>Langhammer</surname><given-names>R</given-names></name>, <name><surname>Stegmann</surname><given-names>T</given-names></name>, <name><surname>Hindricks</surname><given-names>G</given-names></name>, <name><surname>Laufs</surname><given-names>U</given-names></name>, <etal>et al</etal>. <article-title>Patients’ attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation</article-title>. <source>Clin Res Cardiol</source>. <year>2022</year>;<volume>111</volume>(<issue>1</issue>):<fpage>114</fpage>–<lpage>23</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00392-021-01959-z</pub-id> ; PubMed Central PMCID: PMC8766391.<?supplied-pmid 34709451?><pub-id pub-id-type="pmid">34709451</pub-id>
</mixed-citation>
              </ref>
              <ref id="pone.0289719.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Sihvonen</surname><given-names>R</given-names></name>, <name><surname>Paavola</surname><given-names>M</given-names></name>, <name><surname>Malmivaara</surname><given-names>A</given-names></name>, <name><surname>Itala</surname><given-names>A</given-names></name>, <name><surname>Joukainen</surname><given-names>A</given-names></name>, <name><surname>Nurmi</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear</article-title>. <source>N Engl J Med</source>. <year>2013</year>;<volume>369</volume>(<issue>26</issue>):<fpage>2515</fpage>–<lpage>24</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa1305189</pub-id> .<?supplied-pmid 24369076?><pub-id pub-id-type="pmid">24369076</pub-id>
</mixed-citation>
              </ref>
            </ref-list>
          </back>
          <sub-article article-type="editor-report" id="pone.0289719.r001" specific-use="decision-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0289719.r001</article-id>
              <title-group>
                <article-title>Decision Letter 0</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Carels</surname>
                    <given-names>Vanessa</given-names>
                  </name>
                  <role>Staff Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2023 Vanessa Carels</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Vanessa Carels</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0289719" id="rel-obj001" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>0</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">24 Jul 2023</named-content>
              </p>
              <p>Transauricular nerve stimulation in acute ischaemic stroke requiring mechanical thrombectomy: protocol for a phase 2A, proof-of-concept, sham-controlled randomised trial.</p>
              <p>PONE-D-23-20136</p>
              <p>Dear Dr. Ackland,</p>
              <p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
              <p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
              <p>An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <ext-link xlink:href="http://www.editorialmanager.com/pone/" ext-link-type="uri">http://www.editorialmanager.com/pone/</ext-link>, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <email>authorbilling@plos.org</email>.</p>
              <p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email>onepress@plos.org</email>.</p>
              <p>Kind regards,</p>
              <p>Vanessa Carels</p>
              <p>Staff Editor</p>
              <p>PLOS ONE</p>
              <p>Journal requirements:</p>
              <p>When submitting your revision, we need you to address these additional requirements.</p>
              <p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at</p>
              <p><ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and</p>
              <p>
                <ext-link xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" ext-link-type="uri">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link>
              </p>
              <p>2. Please include “Protocol” in the manuscript title.</p>
              <p>3. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:</p>
              <p>
                <ext-link xlink:href="https://www.mdpi.com/2079-7737/12/4/555/htm" ext-link-type="uri">https://www.mdpi.com/2079-7737/12/4/555/htm</ext-link>
              </p>
              <p>In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.</p>
              <p>4. Thank you for stating the following financial disclosure:</p>
              <p>“UK-RI INNOVATE-UK award”</p>
              <p>Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."</p>
              <p>If this statement is not correct you must amend it as needed.</p>
              <p>Please respond by return e-mail so that we can amend your financial disclosure and competing interests on your behalf.</p>
              <p>5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.</p>
              <p>6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.</p>
              <p>7. We note that Figure 2 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: <ext-link xlink:href="http://journals.plos.org/plosone/s/licenses-and-copyright" ext-link-type="uri">http://journals.plos.org/plosone/s/licenses-and-copyright</ext-link>.</p>
              <p>We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:</p>
              <p>1. You may seek permission from the original copyright holder of Figure 2 to publish the content specifically under the CC BY 4.0 license.</p>
              <p>We recommend that you contact the original copyright holder with the Content Permission Form (<ext-link xlink:href="http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf" ext-link-type="uri">http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf</ext-link>) and the following text:</p>
              <p>“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”</p>
              <p>Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.</p>
              <p>In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”</p>
              <p>2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.</p>
            </body>
          </sub-article>
          <sub-article article-type="editor-report" id="pone.0289719.r002" specific-use="acceptance-letter">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pone.0289719.r002</article-id>
              <title-group>
                <article-title>Acceptance letter</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Carels</surname>
                    <given-names>Vanessa</given-names>
                  </name>
                  <role>Staff Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2023 Vanessa Carels</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Vanessa Carels</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article ext-link-type="doi" xlink:href="10.1371/journal.pone.0289719" id="rel-obj002" related-article-type="reviewed-article"/>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">24 Aug 2023</named-content>
              </p>
              <p>PONE-D-23-20136 </p>
              <p>Transauricular nerve stimulation in acute ischaemic stroke requiring mechanical thrombectomy: protocol for a phase 2A, proof-of-concept, sham-controlled randomised trial. </p>
              <p>Dear Dr. Ackland:</p>
              <p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. </p>
              <p>If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <email>onepress@plos.org</email>.</p>
              <p>If we can help with anything else, please email us at <email>plosone@plos.org</email>. </p>
              <p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
              <p>Kind regards, </p>
              <p>PLOS ONE Editorial Office Staff</p>
              <p>on behalf of</p>
              <p>Dr. Vanessa Carels </p>
              <p>Staff Editor</p>
              <p>PLOS ONE</p>
            </body>
          </sub-article>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
